Clinical Trials Browser

Phase 2 × UNKNOWN × Colonic Neoplasms × Clear all

NCT05279677 2022-08-23

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms